Is 25 mg of Trazodone Enough for Sleep?

For many people, 25 mg of trazodone is enough to improve sleep, and one retrospective study found that 25 mg was actually the most common dose among patients who responded well to trazodone for chronic insomnia. That said, trazodone is not a one-size-fits-all medication, and what works depends on body weight, the nature of your sleep problem, other medications, and individual sensitivity. The story behind this low dose is more interesting than a simple yes or no.

Why Such a Small Dose Can Work

Trazodone was originally developed and approved as an antidepressant, typically prescribed at 150 to 400 mg per day for depression. Its sleep-promoting effects are essentially a side effect that clinicians turned into a feature. At low doses, the drug’s sedating properties dominate without producing the full antidepressant action, which requires much higher blood levels. The sedation comes from trazodone blocking several receptor types in the brain, including serotonin 2A receptors, histamine H1 receptors, and alpha-1A adrenergic receptors.¹ That triple mechanism is why even a modest dose can make you feel drowsy enough to fall asleep and stay asleep longer.

Earlier research from the 1980s and 1990s used trazodone at 100 mg or more for insomnia, typically in people who were also depressed. Since the 2000s, prescribing patterns shifted toward lower doses for sleep problems in people without depression.² That shift happened because clinicians noticed that much of the sleep benefit showed up at doses well below the antidepressant range, with fewer side effects to go along with it.

Evidence That 25 mg Holds Its Own

A retrospective study comparing trazodone and mirtazapine for chronic insomnia found that both drugs helped more than 60 percent of patients, with no meaningful difference between the two. The more telling detail: among patients who responded to trazodone, the largest group (about 38 percent of responders) was taking just 25 mg. Even more striking, patients on lower doses of trazodone (25 to 75 mg) had a significantly higher success rate than those on higher doses (100 to 150 mg).³ That finding might seem counterintuitive, but it makes sense when you consider that side effects are dose-dependent. At higher doses, drowsiness the next morning, dizziness, or other complaints may offset the sleep benefit and lead patients to stop taking the medication or rate it as unhelpful.

A systematic review of the broader trazodone-for-insomnia literature concluded that there are adequate data supporting the efficacy and safety of low-dose trazodone for treating insomnia, and that side effects scale with dose, with drowsiness being the most common complaint.² So while the evidence base for 25 mg specifically is not as deep as, say, the evidence for approved insomnia drugs at their standard doses, the pattern across studies consistently points toward lower doses doing the job for a meaningful share of patients.

What Trazodone Actually Does to Your Sleep

Beyond just making you drowsy, trazodone changes the structure of your sleep in ways that many researchers consider favorable. A meta-analysis of polysomnographic studies (where sleep is measured with electrodes, not just questionnaires) found that trazodone increased total sleep time by roughly 40 minutes, shortened the time it took to fall into sustained sleep by about 19 minutes, and reduced nighttime awakenings. It also boosted deep sleep (stage N3) and decreased time spent in the lightest sleep stage.⁴ More time in deep sleep is generally a good thing: that is the stage most associated with physical restoration and feeling refreshed in the morning.

An older but frequently cited study confirmed that trazodone increased slow-wave (deep) sleep while reducing REM sleep. Interestingly, it also found that subjective sleep quality improved even when objective sleep duration did not always change dramatically, which suggests the quality of sleep matters as much as the quantity.⁵ In other words, you might not necessarily clock more hours, but the hours you get feel more restorative.

One meta-analysis of placebo-controlled trials struck a more cautious note, finding that trazodone significantly reduced the number of nighttime awakenings compared to placebo but did not reach statistical significance for sleep latency, total sleep time, or wake time after sleep onset.⁶ The discrepancy between meta-analyses likely comes down to which studies they included and how outcomes were measured. The overall picture is that trazodone helps, but its strongest suit may be keeping you asleep rather than putting you to sleep faster.

When 25 mg Probably Is Not Enough

If your insomnia is driven by an underlying condition like depression, anxiety, or chronic pain, 25 mg alone may fall short. Trazodone has shown clear benefit for insomnia that occurs as a side effect of other antidepressants (SSRIs in particular), but those studies typically used 50 to 100 mg. One trial in patients with SSRI-associated insomnia found that about two-thirds of patients improved with trazodone, compared to only 13 percent on placebo.⁷ That is a strong result, but the dose used was higher than 25 mg.

Body size, metabolism, and how long you have been dealing with insomnia all play a role. Someone with severe, longstanding sleep-maintenance insomnia (waking at 2 a.m. and lying awake for hours) may find 25 mg takes the edge off but does not solve the problem. A study of psychiatric inpatients found that after trazodone 50 mg failed, increasing to 100 mg was comparable in effectiveness to switching to doxepin 25 mg, with neither showing a clear advantage.⁸ That tells you something about the ceiling for dose escalation: doubling the dose does not always double the benefit.

The practical approach most clinicians take is to start at 25 or 50 mg and adjust based on response. If 25 mg gives you restful sleep without morning grogginess, there is little reason to increase it. If it is not doing enough after a week or two, moving up to 50 mg is the standard next step.

Side Effects at 25 mg Versus Higher Doses

Side effects with trazodone are dose-dependent, which is one of the strongest arguments for staying at the lowest effective dose. The most common complaint is next-day drowsiness, and at 25 mg this tends to be mild or absent for most people. At higher doses, the sedation can carry into the morning and interfere with driving, work, and concentration.

A controlled study in people with primary insomnia found that trazodone produced small but significant impairments in short-term memory, verbal learning, balance, and arm muscle endurance.⁹ These effects were modest, but they are worth knowing about if your job or daily routine requires sharp cognitive performance early in the day. Taking it earlier in the evening (rather than right before bed) and sticking to the lowest effective dose both help minimize morning-after fog.

Trazodone reaches peak blood levels about two hours after you swallow it, and food affects how it is absorbed.¹⁰ Taking it on an empty stomach can speed up absorption and make the sedation hit faster and harder, which may or may not be what you want. If you experience nausea (a less common side effect), taking it with a small snack can help.

One side effect that gets outsized attention is priapism, a prolonged and painful erection in men. A survey of male patients on trazodone at doses of 50 to 100 mg found that about 8 percent developed prolonged erections, and most of them had not been warned about the risk beforehand.¹¹ This is a rare but serious complication that requires immediate medical attention. The risk at 25 mg is likely lower, since it was studied at higher doses, but it is something men should be aware of before starting.

Special Risks for Older Adults

Trazodone is one of the most commonly prescribed sleep aids for older adults, but that population faces specific hazards. The drug’s alpha-1 adrenergic blockade can cause blood pressure to drop when you stand up, a problem called orthostatic hypotension. In a study of geriatric outpatients with high blood pressure, those taking trazodone had a significantly greater blood pressure drop upon standing and a much higher rate of syncope (fainting) and falls: about 58 percent experienced syncope or falls, compared to 21 percent of similar patients not taking trazodone. Trazodone use predicted these events independently of age, disability, and fall history.¹²

A larger claims-based study reinforced this concern, finding that older adults receiving insomnia medications experienced more than twice the odds of falls compared to those not taking such drugs, and patients on trazodone or benzodiazepines carried the greatest risk.¹³ For an older person living alone, a nighttime fall can be life-changing. If you are over 65 and considering trazodone, even at 25 mg, it is worth discussing fall risk with your prescriber and taking precautions like keeping a clear path to the bathroom and using nightlights.

What Sleep Medicine Guidelines Say

Here is where things get a bit awkward for trazodone. The American Academy of Sleep Medicine’s clinical practice guideline actually recommends against using trazodone for insomnia, though with a “weak” strength of recommendation.¹⁴ That does not mean the drug does not work; it means the guideline panel felt the evidence base was not strong enough relative to FDA-approved insomnia drugs like suvorexant, lemborexant, or low-dose doxepin. Trazodone has never gone through the rigorous FDA approval process specifically for insomnia, so the large-scale, gold-standard trials that regulators require simply do not exist for this indication.

Despite that guideline, trazodone remains one of the most prescribed medications for insomnia in the United States. Among roughly 5.8 million patients with insomnia in one large database, about 18 percent were prescribed trazodone.¹⁵ Clinicians keep reaching for it because it is inexpensive, generic, widely available, carries a lower abuse potential than benzodiazepines or Z-drugs, and decades of clinical experience back it up even if the formal trial data are thinner than ideal. That gap between guideline skepticism and prescribing reality is one of the more interesting tensions in sleep medicine.

Trazodone and the Brain Over Time

A concern some people have with any sedating drug is whether it dulls cognition over months or years. A systematic review examining trazodone’s effects on human cognition found a nuanced picture: out of 16 studies reviewed, seven showed no effect on cognition, five showed a positive effect (improved cognition or slower cognitive decline), and four showed a negative effect (impaired function). The reviewers proposed a pattern in which short-term, acute use is more likely to impair cognitive performance while long-term use may actually protect against cognitive deterioration.¹⁶

That finding is preliminary and should not be taken as proof that trazodone prevents dementia. But it is reassuring in the sense that long-term low-dose use does not appear to cause the kind of cumulative cognitive damage that some people worry about with sedating medications. The studies in this review used varying doses and populations, so it is difficult to draw firm conclusions about 25 mg specifically. Still, the overall signal does not raise red flags for chronic use at low doses.

Who Takes Trazodone for Sleep and Why It Persists

Real-world prescribing data paint an interesting demographic picture. The typical trazodone-for-insomnia patient is a woman in her late 40s, and the most common coexisting conditions are anxiety, depression, and high blood pressure.¹⁵ About one in ten has a history of substance abuse, which partly explains why trazodone is favored: unlike benzodiazepines or “Z-drugs” like zolpidem, trazodone is not a controlled substance, and it carries minimal potential for dependence or misuse.

The systematic review literature also supports trazodone’s effectiveness for insomnia linked to depression, dementia, and even SSRI side effects.² That versatility across different causes of insomnia, combined with its safety profile relative to habit-forming alternatives, explains why it continues to hold a dominant position in insomnia prescribing despite the lukewarm guideline recommendation. For many prescribers, a drug that works, is cheap, is not addictive, and has been around for decades is hard to replace with a newer branded medication that may cost 50 times as much.

Whether 25 mg is enough for you personally depends on factors no article can assess from a distance: the severity and pattern of your insomnia, your other medications, your age and overall health, and how sensitive you are to sedating drugs. But the evidence suggests that starting at 25 mg is a sound strategy, that many people do well at that dose long-term, and that there is room to adjust upward if needed without jumping to doses that carry meaningfully more side effects.

1
Neuroscience Applied. Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability
2
PubMed Central. Trazodone for Insomnia: A Systematic Review
3
PubMed. Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study
4
Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis
5
PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration
6
PubMed. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials
7
PubMed. Trazodone for antidepressant-associated insomnia
8
PubMed Central. Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
9
PubMed Central. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs
10
PubMed Central. Pharmacokinetics of single oral dose trazodone: a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
11
PubMed Central. Pretreatment screening and counseling on prolonged erections for patients prescribed trazodone
12
PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension
13
PubMed Central. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
14
PubMed Central. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
15
PubMed. Real-World Characteristics and Treatment Patterns of Patients With Insomnia Prescribed Trazodone in the United States
16
PubMed Central. The effects of trazodone on human cognition: a systematic review